PHILADELPHIA, PA — PCI Pharma Services has secured a new round of strategic investment, with Bain Capital joining existing lead investor Kohlberg and reinvestment partner Mubadala Investment Company to support the company’s continued expansion. The deal also includes continued minority backing from Partners Group. While financial details of the private transaction remain undisclosed, the move marks a significant milestone in PCI’s efforts to scale its global operations.
Headquartered in Philadelphia, PCI Pharma Services specializes in integrated pharmaceutical development, manufacturing, and packaging services. The company has more than 50 years of experience and has supported over 450 product launches in the past five years alone. PCI’s growth is being driven by increasing demand for biologics and specialized drug therapies, along with a strong track record of helping clients accelerate time to market.
The new investment will support PCI’s strategy to grow both organically and through acquisitions. Key priorities include expanding sterile fill-finish injectables, high-potency manufacturing, and other specialized capabilities—particularly within the U.S., where the company plans to strengthen pharmaceutical supply chain infrastructure.
CEO Salim Haffar, who will continue to lead PCI, described the investment as a vote of confidence in the company’s transformation into a global contract development and manufacturing organization (CDMO). “I am grateful for the ongoing support of our existing investors and enthusiastically welcome Bain Capital and their deep, global healthcare and life science capabilities and expertise,” said Haffar. “Together we will grow PCI’s commercial, clinical trial services, and development and manufacturing businesses to meet the future demands of our biopharmaceutical customers.”
Matt Jennings, Chairman of PCI and Operating Partner at Kohlberg, credited the management team for driving the company’s success. “PCI’s world-class management team, combined with the support of experienced industry investors, has proven to be a very successful formula,” he said. “We are delighted for Bain Capital to join PCI’s investor base.”
Bain Capital Partner Devin O’Reilly highlighted PCI’s industry position and potential. “Anchored by an innovative, advanced platform that is consistently growing and setting new standards for the industry, PCI Pharma has built a well-deserved reputation as a differentiated partner to leading biopharma companies,” said O’Reilly. Fellow Bain Capital Partners Andrew Kaplan and Christina Dix also emphasized their intent to support innovation and patient outcomes through the firm’s global healthcare expertise.
Chris Anderson, Senior Partner at Kohlberg, described PCI’s evolution into a global CDMO as a success story. “We are thrilled to be partnering with Bain Capital and are aligned to make new investments that will further elevate the company’s capabilities and growth for many years to come.”
Mubadala’s Head of Healthcare, Mina Hamoodi, said the reinvestment reflects strong confidence in PCI’s leadership and mission. “We look forward to partnering with Bain and Kohlberg, and working closely with PCI’s outstanding management team, as the company enters its next chapter of accelerated growth.”
Partners Group’s Sujit John also reaffirmed support for PCI’s market positioning, noting the company’s “world-class capabilities strategically position the Company to be the partner of choice for customers.”
The transaction is backed by a network of top-tier financial and legal advisors. Jefferies served as lead financial advisor to PCI, with Moelis & Company as co-advisor. Morgan Stanley and BofA Securities advised Bain Capital, while Citi advised Mubadala. Legal counsel included Paul, Weiss for PCI and Kohlberg; Kirkland & Ellis for Bain Capital; Skadden, Arps for Mubadala; and Ropes & Gray for Partners Group.
The investment positions PCI to scale operations and service offerings to meet growing demand across the pharmaceutical development lifecycle.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.